Markets:

Overview

News

Currencies

International

Treasuries

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

5.050 +0.090 (+1.81%)

Streaming Delayed Price Updated: 9:30 AM EDT, Jun 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alterity Therapeutics Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review

February 06, 2024

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week

January 29, 2024

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones

January 22, 2024

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 15, 2024

Via Benzinga

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

December 21, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 05, 2023

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket ↗

December 05, 2023

Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted better-than-expected results for its third quarter and issued a stro

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 05, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 05, 2023

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning!

Via InvestorPlace

Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress

December 04, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Why Is Alterity Therapeutics (ATHE) Stock Up 150% Today? ↗

December 04, 2023

Although Alterity Therapeutics revealed encouraging data with its PD therapeutic candidate, ATHE stock still faces challenges.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 04, 2023

Via Benzinga

Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data ↗

December 04, 2023

ATHE stock soared after Alterity Therapeutics disclosed promising new clinical trial data for its Parkinson's disease treatment.

Via Investor's Business Daily

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 04, 2023

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...

Via Benzinga

Nasdaq Down Over 100 Points; Alaska Air To Acquire Hawaiian Airlines ↗

December 04, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 100 points on Monday. Following the market opening Monday, the Dow traded down 0.13% to 36,198.88 while the NASDAQ fell...

Via Benzinga

Topics Stocks

Why Is Neurodegenerative Disease-Focused Alterity Therapeutics Stock Trading Over 200% Higher Today? ↗

December 04, 2023

Alterity Therapeutics Inc (NASDAQ: ATHE) shares are trading higher after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 04, 2023

Via Benzinga

Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease

December 04, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy

November 27, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 23, 2023

Via Benzinga

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 22, 2023

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 22, 2023

Via Benzinga

Dow Surges 150 Points; US Jobless Claims Decline Sharply ↗

November 22, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 150 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.43% to 35,239.40 while the NASDAQ...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 22, 2023

Via Benzinga

Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 22, 2023

Shares of Guess?, Inc. (NYSE: GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 22, 2023

Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning!

Via InvestorPlace

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434

November 16, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy

November 08, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Appendix 4C – Q1 FY24 Quarterly Cash Flow Report

October 30, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.